Genetically Modified Stem Cells are Effective Against Acute Respiratory Diseases
News Jun 18, 2013
Study results were published in the American Journal of Respiratory Cell and Molecular Biology.
Acute lung injury
Acute lung injury and its more severe manifestation, the acute respiratory distress syndrome, are characterized by very severe inflammatory processes that damage the lungs with a mortality of between 40% and 50%. Currently there is no effective treatment beyond palliative care and mechanical assistance to breath.
"In the last years we have been working in the administration of human mesenchymal stem cells from adipose tissue obtained from liposuction in different pathologies," said the researcher of Human Molecular Genetics reserach group at IDIBELL Josep Maria Aran. "We have found that these stem cells are able to easily reach the lungs and there, secrete anti-inflammatory substances and growth factors."
The studies conducted so far with these cells have shown a positive effect. IDIBELL and VHIR researchers have introduced a genetic modification in these cells that improves treatment.
The cytokine IL33 is a protein that acts as an alarm signal in these patients. When the damage into the lungs begins, the cells secrete this highly proinflammatory substance and elicit a very strong immune system answer.
"We believed," says Aran, "that if we modified genetically mesenchymal stem cells to secrete a molecule antagonist of IL-33, we could stop the inflammatory process and we found that, in mice, the effect was more positive than unmodified cells: regeneration of lung tissue and practically nullifies the inflammatory process in the lungs. "
IDIBELL has signed a licensing agreement with the Basque company Histocell for this genetic modification and currently they are working to make this "smart drug" may reach the clinical stage and try to patients.
Innate Reaction of Hematopoietic Stem Cells to Severe InfectionsNews
Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide, without signals from growth factors.READ MORE
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Transgenic Animals - Micromanipulation Techniques
Apr 10 - Apr 11, 2018
EMBO Practical Course: Extracellular Vesicles: From Biology to Biomedical Applications
Apr 09 - Apr 13, 2018
EMBO | EMBL Symposium: Tissue Self-Organisation: Challenging the Systems
Mar 11 - Mar 14, 2018
EMBL Course: Brillouin Microscopy: Emerging Tool for Probing Mechanical Properties of Living Cells
Jan 17 - Jan 19, 2018